Amyotrophic lateral sclerosis disease modifying therapeutics:a cell biological perspective  

作　　者：Bor Luen Tang 

机构地区：[1]Department of Biochemistry,Yong Loo Lin School of Medicine,National University Health System [2]NUS Graduate School forIntegrative Sciences and Engineering,National University ofSingapore,Singapore

出　　处：《Neural Regeneration Research》2017年第3期407-408,共2页中国神经再生研究（英文版）

基　　金：supported by the NUS Graduate School for Integrative Sciences and Engineering

摘　　要：Amyotrophic lateral sclerosis（ALS）is a progressively fatal neuromuscular disorder classically characterized by loss of upper and lower motor neurons from the cortex to the spinal cord Diagnosed patients have a median survival of about 3 years and death usually results from eventual respiratory failure.Amyotrophic lateral sclerosis（ALS）is a progressively fatal neuromuscular disorder classically characterized by loss of upper and lower motor neurons from the cortex to the spinal cord Diagnosed patients have a median survival of about 3 years and death usually results from eventual respiratory failure.

关 键 词：Amyotrophic lateral sclerosis disease modifying therapeutics:a cell biological perspective ALS CELL 

分 类 号：R744.8[医药卫生—神经病学与精神病学]